Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1769

1.

Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review.

Sharaf El Din UAA, Salem MM, Abdulazim DO.

J Adv Res. 2017 Sep;8(5):537-548. doi: 10.1016/j.jare.2016.11.004. Epub 2016 Dec 3. Review.

2.

Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and study design.

Violi F, Targher G, Vestri A, Carnevale R, Averna M, Farcomeni A, Lenzi A, Angelico F, Cipollone F, Pastori D.

Am Heart J. 2017 Jul;189:120-127. doi: 10.1016/j.ahj.2017.04.005. Epub 2017 Apr 18.

PMID:
28625368
3.

Renin-angiotensin system blockade: Finerenone.

Ruilope LM, Tamargo J.

Nephrol Ther. 2017 Apr;13 Suppl 1:S47-S53. doi: 10.1016/j.nephro.2017.02.003. Review.

PMID:
28577743
4.

Renal function markers and metformin eligibility.

Tavares Bello C, Castro Fonseca R, Sousa Santos F, Sequeira Duarte J, Azinheira J, Vasconcelos C.

Minerva Endocrinol. 2017 May 31. doi: 10.23736/S0391-1977.17.02626-8. [Epub ahead of print]

PMID:
28565889
5.

Design of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) Trial.

Rajagopalan S, Alaiti MA, Broadwater K, Goud A, Gaztanaga J, Connelly K, Fares A, Shirazian S, Kreatsoulas C, Farkouh M, Dobre M, Fink JC, Weir MR.

Clin Cardiol. 2017 May 26. doi: 10.1002/clc.22718. [Epub ahead of print]

6.

Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.

Drechsler C, Hayek SS, Wei C, Sever S, Genser B, Krane V, Meinitzer A, März W, Wanner C, Reiser J.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1265-1273. doi: 10.2215/CJN.10881016. Epub 2017 May 11.

PMID:
28495863
7.

Associations between persistent organic pollutants, type 2 diabetes, diabetic nephropathy and mortality.

Grice BA, Nelson RG, Williams DE, Knowler WC, Mason C, Hanson RL, Bullard KM, Pavkov ME.

Occup Environ Med. 2017 Jul;74(7):521-527. doi: 10.1136/oemed-2016-103948. Epub 2017 Apr 24.

PMID:
28438788
8.

Elevated serum level of pancreatic stone protein/regenerating protein (PSP/reg) is observed in diabetic kidney disease.

Li L, Jia D, Graf R, Yang J.

Oncotarget. 2017 Jun 13;8(24):38145-38151. doi: 10.18632/oncotarget.16369.

9.

Impact of end-stage renal disease on glucose metabolism-a matched cohort analysis.

Guthoff M, Wagner R, Vosseler D, Peter A, Nadalin S, Häring HU, Fritsche A, Heyne N.

Nephrol Dial Transplant. 2017 Apr 1;32(4):670-676. doi: 10.1093/ndt/gfx018.

PMID:
28407130
10.

Gut Microbiota in Cardiovascular Health and Disease.

Tang WH, Kitai T, Hazen SL.

Circ Res. 2017 Mar 31;120(7):1183-1196. doi: 10.1161/CIRCRESAHA.117.309715. Review.

PMID:
28360349
11.

Dapagliflozin: potential beneficial effects in the prevention and treatment of renal and cardiovascular complications in patients with type 2 diabetes.

Fioretto P, Avogaro A.

Expert Opin Pharmacother. 2017 Apr;18(5):517-527. doi: 10.1080/14656566.2017.1300253. Epub 2017 Mar 20. Review.

PMID:
28277831
12.

Protocol for Evaluating the Cardio-Ankle Vascular Index to Predict Cardiovascular Events in Japan: A Prospective Multicenter Cohort Study.

Miyoshi T, Ito H, Horinaka S, Shirai K, Higaki J, Orimio H.

Pulse (Basel). 2017 Jan;4(Suppl 1):11-16. doi: 10.1159/000448464. Epub 2016 Dec 23. Review.

13.

Diabetes Mellitus and Younger Age Are Risk Factors for Hyperphosphatemia in Peritoneal Dialysis Patients.

Imtiaz R, Hawken S, McCormick BB, Leung S, Hiremath S, Zimmerman DL.

Nutrients. 2017 Feb 17;9(2). pii: E152. doi: 10.3390/nu9020152.

14.

Dipeptidyl Peptidase-4 Inhibitors in Chronic Kidney Disease: A Systematic Review of Randomized Clinical Trials.

Walker SR, Komenda P, Khojah S, Al-Tuwaijri W, MacDonald K, Hiebert B, Tangri N, Nadurak SWD, Ferguson TW, Rigatto C, Tangri N.

Nephron. 2017;136(2):85-94. doi: 10.1159/000454683. Epub 2017 Feb 9.

PMID:
28178698
15.

En-Bloc Transplant of the Liver, Kidney and Pancreas: Experience from a Latin American Transplant Center.

Caicedo LA, Villegas JI, Serrano O, Millán M, Sepúlveda M, Jiménez D, García J, Posada JG, Mesa L, Duran C, Schweineberg J, Dávalos D, Manzi E, Sabogal A, Aristizabal AM, Echeverri GJ.

Am J Case Rep. 2017 Feb 2;18:114-118.

16.

Peritoneal dialysis is a reasonable option in patients with cardiovascular disease
.

Querido S, Quadros Branco P, Silva Sousa H, Adragão T, Araújo Gonçalves P, Gaspar MA, Diogo Barata J.

Clin Nephrol. 2017 Mar;87 (2017)(3):111-116. doi: 10.5414/CN108957.

PMID:
28128728
17.

Metformin Use in Patients with Historical Contraindications or Precautions [Internet].

Crowley MJ, Diamantidis CJ, McDuffie JR, Cameron B, Stanifer J, Mock CK, Kosinski A, Wang X, Tang S, Williams JW Jr.

Washington (DC): Department of Veterans Affairs (US); 2016 Sep.

18.

Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.

Crowley MJ, Diamantidis CJ, McDuffie JR, Cameron CB, Stanifer JW, Mock CK, Wang X, Tang S, Nagi A, Kosinski AS, Williams JW Jr.

Ann Intern Med. 2017 Feb 7;166(3):191-200. doi: 10.7326/M16-1901. Epub 2017 Jan 3. Review.

PMID:
28055049
19.

[Management of diabetic kidney disease: a summary of European Recommendations 2015].

Staszków M, Mieczkowski M.

Wiad Lek. 2016;69(5):732-735. Review. Polish.

PMID:
28033597
20.

Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial.

Uzu T, Araki SI, Kashiwagi A, Haneda M, Koya D, Yokoyama H, Kida Y, Ikebuchi M, Nakamura T, Nishimura M, Takahara N, Obata T, Omichi N, Sakamoto K, Shingu R, Taki H, Nagai Y, Tokuda H, Kitada M, Misawa M, Nishiyama A, Kobori H, Maegawa H; Shiga Committee for Preventing Diabetic Nephropathy.

PLoS One. 2016 Dec 29;11(12):e0164936. doi: 10.1371/journal.pone.0164936. eCollection 2016.

Supplemental Content

Loading ...
Support Center